WEIGAO GROUP Buys Back 0.22 Million H-Shares for HKD 0.68 Million, Lifts Treasury Stock to 71.51 Million

Bulletin Express11-20 18:23

Shandong Weigao Group Medical Polymer Company Limited (WEIGAO GROUP) disclosed a repurchase of 220,000 H-shares on 20 November 2026 via on-market transactions at prices ranging between HKD 3.095 and HKD 3.12 per share. The volume-weighted average purchase price was HKD 3.1064, bringing total consideration to HKD 0.68 million.

Following the transaction, the company’s outstanding share count (excluding treasury shares) fell marginally by 0.0049 % to 4.45 billion, while treasury shares increased to 71.51 million. Total issued shares remain unchanged at 4.52 billion. The repurchased shares will be retained as treasury stock; none have been cancelled to date.

The buyback forms part of the mandate approved on 29 May 2026, which authorises repurchases of up to 446.46 million shares. Cumulative repurchases under this mandate now stand at 14.18 million shares, equivalent to 3.18 % of the issued share base on the mandate date. In line with Hong Kong listing rules, WEIGAO GROUP is restricted from issuing, selling or transferring treasury shares until 21 December 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment